Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Iatros Health Network Inc -- Ignore unavailable to you. Want to Upgrade?

To: lloyd wood who wrote (505)	1/27/1998 3:42:00 PM
From: Tom Hofmann	Read Replies (1) \| Respond to of 560

Thanks to Malcom for the info below: SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ------------------------------------------------------------------------------ FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934, AS AMENDED DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): JANUARY 6, 1998 IATROS HEALTH NETWORK,INC. ------------------------------------------------------ (Exact Name of Registrant as specified in its charter) DELAWARE 0-20345 23-2596710 ------------------------ ------------------------ ---------------------- (State of Incorporation) (Commission File Number) (IRS Employer Identification Number) 10 PIEDMONT CENTER, SUITE 400 ATLANTA, GEORGIA 30305 (Address of Principal Executive Offices) (Zip Code) REGISTRANT'S TELEPHONE NUMBER: (404) 266-3643 Item 4. (a) The Registrant had engaged Ernst & Young, LLP., Atlanta ("Ernst & Young") as its new independent public accountants on April 25, 1997. Ernst & Young had not to date begun an audit of the Registrant. On December 23, 1997, the Registrant announced the signing of a letter of intent to be acquired by NewCare, Inc. (NASDAQ: NWCA) of Atlanta, Georgia. In recognition of this pending transaction and anticipated audit efficiencies that could not be achieved in transitioning to Ernst & Young, the President/Chief Executive Officer and Executive Vice President/Chief Financial Officer recommended to the Board of Directors that Ernst & Young be dismissed and the Registrant's prior auditors (Asher & Company, Ltd.("Asher")) be engaged to complete the 1997 audit. The Board approved these recommendations. (b) On January 6, 1998 management notified Ernst & Young of their dismissal as the Company's independent accountants. During the eight months of its engagement, there were no disagreements with Ernst & Young on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedures which disagreement(s) would have caused Ernst & Young to make reference to the subject matter of the disagreement(s) in connection with this report. (c) The Registrant engaged Asher as its new independent accountants on January 9, 1998. (d) The Registrant previously filed a Form 8-K dated May 1,1997 reporting the dismissal of Asher & Company, Ltd. and the engagement of Ernst & Young LLP on April 25, 1997 as its independent auditors. That Form 8-K is incorporated by reference. Item 7. Financial Statements and Exhibits (a) Financial statements of businesses acquired. Not applicable. (b) Pro-forma financial information. Not applicable. (c) Exhibits 16.1 Letter from Ernst & Young LLP dated January 13, 1998 addressed to the Securities and Exchange Commission regarding the change in certifying accountants. 16.2 Current Report on Form 8-K dated May 1, 1997 with letter from Asher & Company, Ltd. dated May 1,1997 addressed to the Securities and Exchange Commission regarding the change in certifying accountants. Exhibit 16.1 to FORM 8-K January 13, 1998 Securities and Exchange Commission 450 Fifth Street N.W. Washington, D.C. 20549 Gentlemen: We have read Item 4 of Form 8-K dated January 13, 1998 of Iatros Health Network, Inc. and are in agreement with the statements contained in the first two sentences of paragraph 4(a) and the statements contained in 4(b) and 4(d) therein. We have no basis to agree or disagree with other statements of the registrant contained therein. ERNST & YOUNG LLP